In the later stages of infection, the released berberine exerted anti-inflammatory and antioxidant effects, inducing macrophage conversion to the anti-inflammatory M2 type and promoting angiogenesis (upregulation of vascular endothelial growth factor (VEGF) secretion) and tissue repair. The gene discussed is VEGFA; the disease is infection.